Role of the prostaglandin E2 receptor subtype EP1 in cisplatin-induced nephrotoxicity

被引：0
|
作者：
Kojima, Fumiaki [1 ,3 ]
Yuhki, Koh-ichi [1 ,3 ]
Kashiwagi, Hitoshi [1 ,3 ]
Kumei, Shima [1 ,3 ]
Narumiya, Shuh [2 ,3 ]
Ushikubi, Fumitaka [1 ,3 ]
机构：
[1] Asahikawa Med Univ, Dept Pharmacol, Asahikawa, Hokkaido 0788510, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan
[3] Japan Sci & Technol Agcy, CREST, Tokyo, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2013年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：167P / 167P
页数：1
相关论文
共 50 条
  • [31] Corticotropin-releasing hormone increases the expression of the prostaglandin E2 receptor subtype EP1 in amnion WISH cells
    Spaziani, EP
    O'Brien, WF
    Benoit, RR
    Gould, SF
    BIOLOGY OF REPRODUCTION, 2000, 62 (01) : 23 - 26
  • [32] Prostaglandin E2 EP1 receptor enhances TGF-β1-induced mesangial cell injury
    Chen, Xu
    Jiang, Daishan
    Wang, Jing
    Chen, Xiaolan
    Xu, Xiaolin
    Xi, Peipei
    Fan, Yaping
    Zhang, Xiaoyan
    Guan, Youfei
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 35 (01) : 285 - 293
  • [33] Prostaglandin E receptor subtype EP1 deficiency reduces the colon cancer development
    Kawamori, T
    Zhou, DH
    Wakabayashi, K
    Maruyama, T
    Narumiya, S
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1320S - 1320S
  • [34] Prostaglandin e receptor subtype EP1 regulates dopamine receptor signaling in the striatum.
    Kitaoka, Shiho
    Furuyashiki, Tomoyuki
    Nishi, Akinori
    Shuto, Takahide
    Koyasu, Sho
    Matsuoka, Toshiyuki
    Narumiya, Shuh
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 135P - 135P
  • [35] Prostaglandin E receptor subtype EP1 deficiency inhibits colon cancer development
    Kawamori, T
    Kitamura, T
    Watanabe, K
    Uchiya, N
    Maruyama, T
    Narumiya, S
    Sugimura, T
    Wakabayashi, K
    CARCINOGENESIS, 2005, 26 (02) : 353 - 357
  • [36] Vasorelaxation induced by prostaglandin E2 in human pulmonary vein:: role of the EP4 receptor subtype
    Foudi, N.
    Kotelevets, L.
    Louedec, L.
    Leseche, G.
    Henin, D.
    Chastre, E.
    Norel, X.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (08) : 1631 - 1639
  • [37] Prostaglandin E2 potentiates dopamine D1 receptor signaling via EP1
    Kitaoka, Shiho
    Koyasu, Sho
    Nishi, Akinori
    Furuyashiki, Tomoyuki
    Matsuoka, Toshiyuki
    Narumiya, Shuh
    NEUROSCIENCE RESEARCH, 2006, 55 : S170 - S170
  • [38] The effect of altered expression of the EP1 receptor for prostaglandin E2 in skin tumor development
    Surh, Inok
    Fischer, Susan M.
    CANCER RESEARCH, 2006, 66 (08)
  • [39] Molecular characterization of prostaglandin F receptor (FP) and E receptor subtype 1 (EP1) in zebrafish
    Kwok, Amy H. Y.
    Wang, Yajun
    Leunga, Frederick C.
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2012, 178 (02) : 216 - 226
  • [40] Adaptive gastric cytoprotection is mediated by prostaglandin e receptor Ep1 but not Ep4 subtype
    Tanigami, Mayu
    Hatazawa, Ryo
    Ogura, Michitaka
    Ito, Yasuyuki
    Tanaka, Akiko
    Takeuchi, Koji
    GASTROENTEROLOGY, 2007, 132 (04) : A410 - A410
12345